Calcium content in automated peritoneal dialysis solutions

Contributions to Nephrology

Volumn 129, Issue , 1999, Pages 168-176

  Hutchison, Alastair ^a   Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DIALYSIS FLUID;

HUMAN; ION TRANSPORT; METABOLISM; PERITONEAL DIALYSIS; REVIEW;

CALCIUM; DIALYSIS SOLUTIONS; HUMANS; ION TRANSPORT; PERITONEAL DIALYSIS;

EID: 0032622498     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060017     Document Type: Article

References (26)

1. 3? Perit Dial Int 1989;9:325-328.
2. Kurtz P, Roth P, Werner E, Vlachojannis J, Grutzmacher P: Factors influencing transperitoneal calcium balance during CAPD. ASAIO J 1992;38:M589-M592.
3. Merchant M, Hutchison A, Butler SJ, Boulton H, Hinchliffe R, Gokal R: Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. Adv Perit Dial 1992;8:365-368.
4. Hutchison A, Merchant M, Boulton HF, Hinchcliffe R, Gokal R: Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/l calcium and 0.25 mmol/l magnesium dialysis fluid. Perit Dial Int 1993;13:219-223.
5. Hutchison A, Gokal R: Improved solutions for peritoneal dialysis: Physiological calcium solutions, osmotic agents and buffers. Kidney Int 1992;42(suppl 38):153-159.
6. Banalagay EE, Bernadini J, Piraino B: Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/1 calcium dialysate. Adv Perit Dial 1993;9:271-273.
7. Montenegro J, Saracho R, Aquirre R, Martinez I: Calcium mass transfer in CAPD: The role of convective transport. Nephrol Dial Transplant 1993;8:1234-1236.
8. Sieniawska M, Roszkowska-Blaim M, Wojciechowska B: The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD. Perit Dial Int 1996;16(suppl 1):567-569.
9. Chagnac A, Ori Y, Weinstein T, Herman M, Korzets A, Zevin D, Hirsh J, Gafter U: Calcium balance during pulse alfacalcidol therapy for secondary hyperparathroidism in CAPD patients treated with 1.0 and 1.25 mmol/l dialysate calcium. Am J Kidney Dis 1999;33:82-86.
10. Pagliari B, Baretta A, De Cristofaro V, Sama F, Cantaluppi A, Martis L, Imbasciati E: Short-term effects of low-calcium dialysis solution on calcium mass transfer, ionised calcium, and parathyroid hormone in CAPD Patients. Perit Dial Int 1991;11:326-329.
11. Weinreich T, Colombi A, Echterhoff HH, Mielke G, Nebel M, Ziegelmayer C, Passlick-Deetjen J: Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM). Perit Dial Int 1993;13(suppl 2):467-470.
12. Malluche HH, Ritz E, Lange HP, Schoeppe W: Changes of bone histology during maintenance hemodialysis at various levels of dialysate Ca concentration. Clin Nephrol 1976;6:440-447.
13. Alfry AC, Le Gendre GR, Kaehney WD: The dialysis encephalopathy syndrome: Possible aluminium intoxication. N Engl J Med 1976;315:157-161.
14. Slatopolsky E, Weerts C, Lopez-Hilker J, Norwood K, Zink M, Windus D, Delmez J: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl JMed 1986;315:157-161.
15. Hercz G, Kraut JA, Andress DA, Howard N, Robert C, Shinaberger JH, Sherrard D, Coburn J: Use of calcium carbonate as a phosphate binder in dialysis patients. Miner Electrolyte Metab 1986;12:314-319.
16. Meric F, Yap B, Bia MJ: Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 1990;16:459-464.
17. Slatopolsky EA, Burke SK, Dillon MA, and The RenaGel Study Group: RenaGel, a nonabsorbed calcium- and aluminium-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 1999;55:299-307.
18. Dewberry K, Fox JS, Stewart J, Murray JR, Hutchison AJ: Lanthanum carbonate: A novel noncalcium containing phosphate binder (abstract). J Am Soc Nephrol 1997;8:560A .
19. Peers E, Gokal R: Icodextrin: Overview of clinical experience. Perit Dial Int 1997;17:22-26.
20. Ritz E, Passlick-Deetjen J, Zeier M, Stefanski A: Prescription of calcium concentration and PTH control. Perit Dial Int 1996;16(suppl 1):300-304.
21. Ritz E, Passlick-Deetjen J, Lippert J: What is the appropriate dialysate calcium concentration for the dialysis patient? Nephrol Dial Transplant 1996;11(suppl 3):91-95.
22. Armstrong A, Beer J, Noonan K, Cunningham J: Reduced calcium dialysate in CAPD patients: Efficacy and limitations. Nephrol Dial Transplant 1997;12:1223-1228.
23. Hutchison AJ, Freemont AJ, Boulton HF, Gokal R: Low-calcium dialysis fluid and oral calcium carbonate in CAPD: A method of controlling hyperphosphataemia whilst minimising aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992;7:1219-1225.
24. Hutchison AJ, Whitehouse RW, Freemont AJ, Adams JE, Mawer EB, Gokal R: Histological, radiological and biochemical features of adynamic bone lesions in CAPD patients. Am J Nephrol 1994;14:19-29.
25. Shigematsu T, Kawaguchi Y, Kubo H, Nakayama H, Kato N, Yamamoto H et al: Low calcium (1.25 mmol/l) dialysate can normalise relative hypoparathyroidism in CAPD patients with low bone turnover. Adv Perit Dial 1996;12:250-256.
26. Brandi L, Nielsen PK, Bro K, Daugaard H, Olgaard K: Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysate (1.25 mmol/l) on secondary hyperparathyroidism in patients on CAPD. J Intern Med 1998;244:121-131.